Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer

BACKGROUND: Sagopilone is the first fully synthetic epothilone in clinical development and has demonstrated promising preclinical activity. This phase I/II, prospective, open-label trial investigated the efficacy and safety of sagopilone plus carboplatin in patients with recurrent platinum-sensitive...

Full description

Saved in:
Bibliographic Details
Main Authors: McMeekin, S, Patel, R, Verschraegen, C, Celano, P, Burke, J, Plaxe, S, Ghatage, P, Giurescu, M, Stredder, C, Wang, Y, Schmelter, T
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2012
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251849/
https://ncbi.nlm.nih.gov/pubmed/22108514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.499
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items